Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 2000 Feb 8;162(3):351–355.

Tuberculosis: 13. Control of the disease among aboriginal people in Canada

J M FitzGerald 1, L Wang 1, R K Elwood 1
PMCID: PMC1231016  PMID: 10693593

Full Text

The Full Text of this article is available as a PDF (209.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Behr M. A., Warren S. A., Salamon H., Hopewell P. C., Ponce de Leon A., Daley C. L., Small P. M. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet. 1999 Feb 6;353(9151):444–449. doi: 10.1016/s0140-6736(98)03406-0. [DOI] [PubMed] [Google Scholar]
  2. Blenkush M. F., Korzeniewska-Kozela M., Elwood R. K., Black W., FitzGerald J. M. HIV-related tuberculosis in British Columbia: indications of a rise in prevalence and a change in risk groups. Clin Invest Med. 1996 Aug;19(4):271–278. [PubMed] [Google Scholar]
  3. Colditz G. A., Brewer T. F., Berkey C. S., Wilson M. E., Burdick E., Fineberg H. V., Mosteller F. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA. 1994 Mar 2;271(9):698–702. [PubMed] [Google Scholar]
  4. Cummings K. C., Mohle-Boetani J., Royce S. E., Chin D. P. Movement of tuberculosis patients and the failure to complete antituberculosis treatment. Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1249–1252. doi: 10.1164/ajrccm.157.4.9708058. [DOI] [PubMed] [Google Scholar]
  5. Enarson D. A. Tuberculosis: 12. Global disease and the role of international collaboration. CMAJ. 2000 Jan 11;162(1):57–61. [PMC free article] [PubMed] [Google Scholar]
  6. Fanning A. Tuberculosis: 1. Introduction. CMAJ. 1999 Mar 23;160(6):837–839. [PMC free article] [PubMed] [Google Scholar]
  7. Fanning A. Tuberculosis: 6. Extrapulmonary disease. CMAJ. 1999 Jun 1;160(11):1597–1603. [PMC free article] [PubMed] [Google Scholar]
  8. FitzGerald J. M., Houston S. Tuberculosis: 8. The disease in association with HIV infection. CMAJ. 1999 Jul 13;161(1):47–51. [PMC free article] [PubMed] [Google Scholar]
  9. Fitzgerald M. J., Duclos P. The reporting and management of adverse reactions to bacillus Calmette-Guérin (BCG) vaccination. Can Dis Wkly Rep. 1991 May 11;17(19):98–100. [PubMed] [Google Scholar]
  10. Garner P. What makes DOT work? Directly observed therapy. Lancet. 1998 Oct 24;352(9137):1326–1327. doi: 10.1016/s0140-6736(05)60739-8. [DOI] [PubMed] [Google Scholar]
  11. Gaudette L. A., Ellis E. Tuberculosis in Canada: a focal disease requiring distinct control strategies for different risk groups. Tuber Lung Dis. 1993 Aug;74(4):244–253. doi: 10.1016/0962-8479(93)90050-8. [DOI] [PubMed] [Google Scholar]
  12. Grzybowski S., Allen E. A. Tuberculosis: 2. History of the disease in Canada. CMAJ. 1999 Apr 6;160(7):1025–1028. [PMC free article] [PubMed] [Google Scholar]
  13. Halsey N. A., Coberly J. S., Desormeaux J., Losikoff P., Atkinson J., Moulton L. H., Contave M., Johnson M., Davis H., Geiter L. Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection. Lancet. 1998 Mar 14;351(9105):786–792. doi: 10.1016/S0140-6736(97)06532-X. [DOI] [PubMed] [Google Scholar]
  14. Heal G., Elwood R. K., FitzGerald J. M. Acceptance and safety of directly observed versus self-administered isoniazid preventive therapy in aboriginal peoples in British Columbia. Int J Tuberc Lung Dis. 1998 Dec;2(12):979–983. [PubMed] [Google Scholar]
  15. Hershfield E. Tuberculosis: 9. Treatment. CMAJ. 1999 Aug 24;161(4):405–411. [PMC free article] [PubMed] [Google Scholar]
  16. Hershfield E. Tuberculosis: 9. Treatment. CMAJ. 1999 Aug 24;161(4):405–411. [PMC free article] [PubMed] [Google Scholar]
  17. Krysl J., Korzeniewska-Kosela M., Müller N. L., FitzGerald J. M. Radiologic features of pulmonary tuberculosis: an assessment of 188 cases. Can Assoc Radiol J. 1994 Apr;45(2):101–107. [PubMed] [Google Scholar]
  18. Kulaga S., Behr M. A., Schwartzman K. Genetic fingerprinting in the study of tuberculosis transmission. CMAJ. 1999 Nov 2;161(9):1165–1169. [PMC free article] [PubMed] [Google Scholar]
  19. Laszlo A. Tuberculosis: 7. Laboratory aspects of diagnosis. CMAJ. 1999 Jun 15;160(12):1725–1729. [PMC free article] [PubMed] [Google Scholar]
  20. Long R., Cowie R. Tuberculosis: 4. Pulmonary disease. CMAJ. 1999 May 4;160(9):1344–1348. [PMC free article] [PubMed] [Google Scholar]
  21. Long R., Njoo H., Hershfield E. Tuberculosis: 3. Epidemiology of the disease in Canada. CMAJ. 1999 Apr 20;160(8):1185–1190. [PMC free article] [PubMed] [Google Scholar]
  22. MacMillan H. L., MacMillan A. B., Offord D. R., Dingle J. L. Aboriginal health. CMAJ. 1996 Dec 1;155(11):1569–1578. [PMC free article] [PubMed] [Google Scholar]
  23. Marciniuk D. D., McNab B. D., Martin W. T., Hoeppner V. H. Detection of pulmonary tuberculosis in patients with a normal chest radiograph. Chest. 1999 Feb;115(2):445–452. doi: 10.1378/chest.115.2.445. [DOI] [PubMed] [Google Scholar]
  24. Menzies D., Tannenbaum T. N., FitzGerald J. M. Tuberculosis: 10. Prevention. CMAJ. 1999 Sep 21;161(6):717–724. [PMC free article] [PubMed] [Google Scholar]
  25. Menzies D., Tannenbaum T. N., FitzGerald J. M. Tuberculosis: 10. Prevention. CMAJ. 1999 Sep 21;161(6):717–724. [PMC free article] [PubMed] [Google Scholar]
  26. Menzies R., Vissandjee B. Effect of bacille Calmette-Guérin vaccination on tuberculin reactivity. Am Rev Respir Dis. 1992 Mar;145(3):621–625. doi: 10.1164/ajrccm/145.3.621. [DOI] [PubMed] [Google Scholar]
  27. Moore R. D., Chaulk C. P., Griffiths R., Cavalcante S., Chaisson R. E. Cost-effectiveness of directly observed versus self-administered therapy for tuberculosis. Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):1013–1019. doi: 10.1164/ajrccm.154.4.8887600. [DOI] [PubMed] [Google Scholar]
  28. Nobert E., Chernick V. Tuberculosis: 5. Pediatric disease. CMAJ. 1999 May 18;160(10):1479–1482. [PMC free article] [PubMed] [Google Scholar]
  29. Nolan C. M., Goldberg S. V., Buskin S. E. Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic. JAMA. 1999 Mar 17;281(11):1014–1018. doi: 10.1001/jama.281.11.1014. [DOI] [PubMed] [Google Scholar]
  30. Schluger N., Ciotoli C., Cohen D., Johnson H., Rom W. N. Comprehensive tuberculosis control for patients at high risk for noncompliance. Am J Respir Crit Care Med. 1995 May;151(5):1486–1490. doi: 10.1164/ajrccm.151.5.7735604. [DOI] [PubMed] [Google Scholar]
  31. Schwartzman K., Menzies D. Tuberculosis: 11. Nosocomial disease. CMAJ. 1999 Nov 16;161(10):1271–1277. [PMC free article] [PubMed] [Google Scholar]
  32. Volmink J., Garner P. Systematic review of randomised controlled trials of strategies to promote adherence to tuberculosis treatment. BMJ. 1997 Nov 29;315(7120):1403–1406. doi: 10.1136/bmj.315.7120.1403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Young T. K., Casson R. I. The decline and persistence of tuberculosis in a Canadian Indian population: implications for control. Can J Public Health. 1988 Sep-Oct;79(5):302–306. [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES